Sign in to fuzzto save your conversations, follow your research and come back anytime.
Strides Pharma Science
SectorHealthcare
In the news
Strides Pharma shares in focus after USFDA issues 3 observations
Strides Pharma surges 10% on USFDA EIR for Bengaluru facility
Strides Pharma's Pivot Path Divestment: Strategic Capital Play
Strides Pharma rises 2.69% after selling Pivot Path stake for ₹100 cr
Strides Pharma gets 5 USFDA observations after Bengaluru inspection
Strides Pharma Q4 profit jumps 51% to ₹129 crore
Strides Pharma Q4 profit surges 54% to ₹127 crore
Strides Pharma acquires Sandoz generic brands in Africa for $12M
Strides Pharma US unit gets closure report after USFDA inspection
Strides Pharma Q3 Results: PAT rises over 2-fold at ₹208.12 crore